Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (61-70 of 218) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Estrogen Deprivation Therapy in Ovarian Cancer: An OpportunityBalkees Abderrahman, V Craig Jordan
Nature|January 12, 2018
Telling details of breast-cancer recurrenceBalkees Abderrahman, V Craig Jordan
Expert Review of Endocrinology & Metabolism|August 1, 2018
The modulation of estrogen-induced apoptosis as an interpretation of the women's health initiative trialsBalkees Abderrahman, V Craig Jordan
Endocrinology|June 23, 2018
Successful Targeted Therapies for Breast Cancer: the Worcester Foundation and Future Opportunities in Women's HealthBalkees Abderrahman, V Craig Jordan
Nature|February 26, 2020
Telling details of breast-cancer recurrenceBalkees Abderrahman, V Craig Jordan
Cell Death & Disease|August 15, 2018
How PERK kinase conveys stress signals to nuclear factor-κB to mediate estrogen-induced apoptosis in breast cancer cells?Ping Fan, V Craig Jordan
Clinical Breast Cancer|March 20, 2002
Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decadeCsaba Gajdos, V Craig Jordan
Seminars in Oncology|December 6, 2006
Steroid receptors and their role in the biology and control of breast cancer growthFernando Cordera, V Craig Jordan
JAMA Oncology|October 7, 2016
Long-term Adjuvant Tamoxifen Therapy and Decreases in Contralateral Breast CancerBalkees Abderrahman, V Craig Jordan
Steroids|June 17, 2014
Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populationsPing Fan, V Craig Jordan
Pageof 22

Showing results (61-70 of 218) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Estrogen Deprivation Therapy in Ovarian Cancer: An OpportunityBalkees Abderrahman, V Craig Jordan
Nature|January 12, 2018
Telling details of breast-cancer recurrenceBalkees Abderrahman, V Craig Jordan
Expert Review of Endocrinology & Metabolism|August 1, 2018
The modulation of estrogen-induced apoptosis as an interpretation of the women's health initiative trialsBalkees Abderrahman, V Craig Jordan
Endocrinology|June 23, 2018
Successful Targeted Therapies for Breast Cancer: the Worcester Foundation and Future Opportunities in Women's HealthBalkees Abderrahman, V Craig Jordan
Nature|February 26, 2020
Telling details of breast-cancer recurrenceBalkees Abderrahman, V Craig Jordan
Cell Death & Disease|August 15, 2018
How PERK kinase conveys stress signals to nuclear factor-κB to mediate estrogen-induced apoptosis in breast cancer cells?Ping Fan, V Craig Jordan
Clinical Breast Cancer|March 20, 2002
Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decadeCsaba Gajdos, V Craig Jordan
Seminars in Oncology|December 6, 2006
Steroid receptors and their role in the biology and control of breast cancer growthFernando Cordera, V Craig Jordan
JAMA Oncology|October 7, 2016
Long-term Adjuvant Tamoxifen Therapy and Decreases in Contralateral Breast CancerBalkees Abderrahman, V Craig Jordan
Steroids|June 17, 2014
Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populationsPing Fan, V Craig Jordan
Pageof 22